Document Detail


Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.
MedLine Citation:
PMID:  20211191     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Neurotensin (NT) is a tridecapeptide that acts as a neuromodulator in the central nervous system mainly through two NT receptors, NTS1 and NTS2. The functional-anatomical interactions between NT, the mesotelencephalic dopamine system, and structures targeted by dopaminergic projections have been studied. The present study was conducted to determine the effects of NT receptor subtypes on dopaminergic function with the use of mice lacking either NTS1 (NTS1(-/-)) or NTS2 (NTS2(-/-)). Basal and amphetamine-stimulated locomotor activity was determined. In vivo microdialysis in freely moving mice, coupled with HPLC-ECD, was used to detect basal and d-amphetamine-stimulated striatal extracellular dopamine levels. In vitro radioligand binding and synaptosomal uptake assays for the dopamine transporters were conducted to test for the expression and function of the striatal pre-synaptic dopamine transporter. NTS1(-/-) and NTS2(-/-) mice had higher baseline locomotor activity and higher basal extracellular dopamine levels in striatum. NTS1(-/-) mice showed higher locomotor activity and exaggerated dopamine release in response to d-amphetamine. Both NTS1(-/-) and NTS2(-/-) mice exhibited lower dopamine D(1) receptor mRNA expression in the striatum relative to wild type mice. Dopamine transporter binding and dopamine reuptake in striatum were not altered. Therefore, lack of either NTS1 or NTS2 alters the dopaminergic system. The possibility that the dysregulation of dopamine transmission might stem from a deficiency in glutamate neurotransmission is discussed. The data strengthen the hypothesis that NT receptors are involved in the pathogenesis of schizophrenia and provide a potential model for the biochemical changes of the disease.
Authors:
Yanqi Liang; Mona Boules; Zhimin Li; Katrina Williams; Tomofumi Miura; Alfredo Oliveros; Elliott Richelson
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-03-06
Journal Detail:
Title:  Neuropharmacology     Volume:  58     ISSN:  1873-7064     ISO Abbreviation:  Neuropharmacology     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-04-26     Completed Date:  2010-07-15     Revised Date:  2013-05-30    
Medline Journal Info:
Nlm Unique ID:  0236217     Medline TA:  Neuropharmacology     Country:  England    
Other Details:
Languages:  eng     Pagination:  1199-205     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Ltd. All rights reserved.
Affiliation:
Neuropsychopharmacology Laboratory, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Corpus Striatum / drug effects,  metabolism
Dextroamphetamine / pharmacology
Dopamine / metabolism*
Dopamine Agonists / pharmacology
Dopamine Plasma Membrane Transport Proteins / metabolism*
Mice
Mice, Knockout
Motor Activity
RNA, Messenger / metabolism
Receptors, Dopamine D1 / metabolism*
Receptors, Dopamine D2 / metabolism*
Receptors, Neurotensin / genetics*,  metabolism
Grant Support
ID/Acronym/Agency:
MH71241/MH/NIMH NIH HHS; R01 MH071241-03S1/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/Dopamine Agonists; 0/Dopamine Plasma Membrane Transport Proteins; 0/Ntsr2 protein, mouse; 0/RNA, Messenger; 0/Receptors, Dopamine D1; 0/Receptors, Dopamine D2; 0/Receptors, Neurotensin; 0/neurotensin type 1 receptor; 51-64-9/Dextroamphetamine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Periodic Acceleration (pGz) Prior to Whole Body Ischemia Reperfusion Injury Provides Early Cardiopro...
Next Document:  Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuro...